Immune and Immune‐Integrated Organoids as NextGeneration Platforms for Disease Modeling
MedComm · 2025-12 · 6 (12)
DOI: 10.1002/mco2.70531 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift MedComm, online erschienen am 18.12.2025. Verfasst von Kimiya Rashidan und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Immunology, School of Medicine Shahid Beheshti University of Medical Sciences Tehran Iran. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 301 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Organoids are three‐dimensional structures that closely resemble the architecture and functions of human organs, offering key advantages over traditional models by better replicating tissue complexity and cellular interactions. These systems have become invaluable tools for disease modeling, drug screening, and regenerative medicine applications. Despite this progress, their lack of immune components limits their usefulness in diseases where immune cells are central drivers of pathology and therapy. The absence of an immune system within organoids limits their physiological relevance, particularly for cancer, inflammation, and autoimmunity research. Immune cell‐containing organoids provide a comprehensive platform for immunotherapy, host–pathogen interactions, regeneration, and immune disorders. This review first highlights the transformative potential of immune cell‐containing organoids across cancer, infection, inflammation, autoimmunity, regeneration, and the modeling of primary lymphoid organs. It then examines current strategies for integrating immune cells into organoids, the variety of immune cell sources employed, and the challenges in maintaining immune cell function. Finally, the role of bioengineering, biobanking, and artificial intelligence in overcoming existing limitations and enhancing immune system modeling is discussed. Overall, this study positions immune cell‐containing organoids as powerful platforms for translational research and precision medicine.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Immunology, School of Medicine Shahid Beheshti University of Medical Sciences Tehran Iran.
- Department of Immunology, School of Medicine Tehran University of Medical Sciences Tehran Iran.
- School of Medicine Iran University of Medical Sciences Tehran Iran.
- The University of Queensland Frazer Institute, Faculty of Health Medicine and Behavioral Sciences The University of Queensland Brisbane Queensland Australia.
ORCID-Profile: Kimiya Rashidan, Abbas Shafiee
Zitieren
APA
Rashidan, K., Ayadilord, M., Hazrati, A., Nazerian, A., Shafiee, A., & Hashemi, S. M. (2025). Immune and Immune‐Integrated Organoids as NextGeneration Platforms for Disease Modeling. MedComm, 6(12). https://doi.org/10.1002/mco2.70531
Vancouver
Rashidan K, Ayadilord M, Hazrati A, Nazerian A, Shafiee A, Hashemi SM. Immune and Immune‐Integrated Organoids as NextGeneration Platforms for Disease Modeling. MedComm. 2025;6(12). doi:10.1002/mco2.70531
BibTeX
@article{Rashidan2025,
author = {Rashidan, Kimiya and Ayadilord, Malaksima and Hazrati, Ali and Nazerian, Amirhossein and Shafiee, Abbas and Hashemi, Seyed Mahmoud},
title = {Immune and Immune‐Integrated Organoids as NextGeneration Platforms for Disease Modeling},
journal = {MedComm},
year = {2025},
volume = {6},
number = {12},
doi = {10.1002/mco2.70531}
}
EUVIMED